E3 ligase Praja1 mediates ubiquitination and degradation of microtubule-associated protein Tau
Shiho Aoki, Wataru OnoderaiD, Akihiko TakashimaiD, Kotaro Kawasaki, Kazuki Imadegawa, Hikaru Kurahashi, Mizuho Oishi, Toru AsahiiD, Yoshiyuki SoedaiD
Abstract
RING-H2 type E3 ligase Praja family is composed of Praja1 and Praja2, which promote the degradation of substrates through the ubiquitin-proteasome system. Both paralogs contribute to neuronal maturation and differentiation, indicating a significant role in the nervous system. Aggregation-prone proteins associated with neurodegenerative diseases, including TDP-43 and -synuclein, are degraded and/or suppressed by Praja1. Furthermore, the expression level of the MAPT gene, which is frequently mutated in Alzheimers, is regulated by Praja2. While the Praja family has been shown to recognize various aggregation-prone proteins as substrates, it has not been determined whether Tau, a key protein that aggregates in tauopathies, is also recognized by Praja proteins. In this study, we show that Praja1, but not Praja2, recognizes Tau as a candidate substrate. We observed that Tau expression in human neuroblastoma SH-SY5Y cells decreased depending on the E3 ligase activity of Praja1. Furthermore, Praja1 polyubiquitinated and interacted with Tau, indicating that it is a target substrate. Next, by combining ancestral sequence reconstruction and mutational analysis, we revealed that the Praja1-Tau interaction began via deletion of the N- and C-terminal regions of Praja1, occurring just after the duplication of the Praja family in the common ancestor of placentals. Lastly, to test whether this interaction is disrupted under pathological conditions, P301L Tau was introduced, resulting in a degradation similar to that of wild-type Tau. These results reveal an unidentified mechanism of Tau proteostasis by Praja1 and may provide insight into the pathogenesis of neurodegenerative diseases, including tauopathy.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 6
- FWCI
- 1.81
- Field percentile
- top 14%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeted degradation of microtubule-associated protein tau using an engineered nanobody-E3 ubiquitin ligase adapter fusion
- Pathological Tau transmission initiated by binding lymphocyte-activation gene 3
Chan Chen, Ramhari Kumbhar, … Xiaobo Mao·Advanced SciencePeer-reviewed·Feb 7, 2024
- ApoE isoforms differentially regulate neuronal membrane proteasomes to shift the threshold for pathological aggregation of endogenous Tau
Victoria Paradise, M Sabu, … KV Ramachandran·bioRxiv·Nov 29, 2022
- The uptake of tau amyloid fibrils is facilitated by the cellular prion protein and hampers prion propagation in cultured cells
Elena De Cecco, Luigi Celauro, … Giuseppe Legname·Journal of NeurochemistryPeer-reviewed·May 12, 2020
- Reduced progranulin increases tau and alpha-synuclein inclusions and alters phenotypes of tauopathy mice via glucocerebrosidase
Hideyuki Takahashi, Sanaea Z. Bhagwagar, … Stephen M. Strittmatter·bioRxiv·Dec 25, 2022
- BAG3 regulation of Rab35 mediates the Endosomal Sorting Complexes Required for Transport /endolysosome pathway and tau clearance
Heng Lin, Maoping Tang, … Gail V.W. Johnson·Biological PsychiatryPeer-reviewed·Nov 10, 2021